🇺🇸 Albuterol-HFA-MDI in United States

11 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Alanine Aminotransferase Increased — 2 reports (18.18%)
  2. Aspartate Aminotransferase Increased — 1 report (9.09%)
  3. Blood Sodium Increased — 1 report (9.09%)
  4. Blood Urea Increased — 1 report (9.09%)
  5. Confusional State — 1 report (9.09%)
  6. Dehydration — 1 report (9.09%)
  7. Hypotension — 1 report (9.09%)
  8. Renal Failure Chronic — 1 report (9.09%)
  9. Rhabdomyolysis — 1 report (9.09%)
  10. Sepsis — 1 report (9.09%)

Source database →

Other Respiratory approved in United States

Frequently asked questions

Is Albuterol-HFA-MDI approved in United States?

Albuterol-HFA-MDI does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Albuterol-HFA-MDI in United States?

Teva Branded Pharmaceutical Products R&D, Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.